FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Progress made in identifying Alzheimer biomarkers

The Wall Street Journal examines the "hot" field of biomarker research for Alzheimer's. Scientists in the U.S. and Europe have identified proteins that can serve as an early warning of Alzheimer's, which in turn would allow for better treatment at an earlier stage for many patients. Researchers from Cornell and the Weill Cornell Medical College say they've found 23 biomarkers for Alzheimer's. Earlier this year, researchers in the U.K. working with Proteome Sciences say they have identified 15 biomarkers for Alzheimer's. Much of this data is preliminary though, and scientists in the field are looking to ongoing studies to confirm the best biomarkers for use in diagnosing patients. Some expect that a new test for Alzheimer's could emerge in the next three to five years, at the earliest.

- read the article from The Wall Street Journal (sub. req.)

Related Articles:
BRNI discovery raises hopes for Alzheimer's test. Report
Marijuana may help prevent Alzheimer's. Report
Alzheimer's group makes switch on research focus. Report

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Research Email Newsletter:
Be the first to comment
More stories about Alzheimer's   biomarkers  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.